Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mebeverine vs placebo with labeling manipulation in children with IBS or FAP-NOS
NL-OMON55563Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of mebeverine in irritable bowel syndrome (IBS) and functional abdominal pain syndrome (CAPS) (4 arms), sponsored by Amsterdam University Medical Center. Started Nov 2018; status: active, not recruiting.
02
Drugs
mebeverine
03
Conditions
irritable bowel syndrome (IBS)functional abdominal pain syndrome (CAPS)
Beyond the preview
Go deeper on NL-OMON55563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55563.